Zogenix Inc Watch

from 10-Q 3 pages Third Amendment to Employment Agreement

from 10-Q 3 pages Second Amendment to Employment Agreement

from 10-Q 3 pages Amendment to Employment Agreement

from 10-Q 2 pages Zogenix, Inc. Independent Director Compensation Policy

from 8-K 18 pages Zogenix, Inc. 2021 Employment Inducement Equity Incentive Award Plan Article 1 Purpose

from 8-K 21 pages Zogenix, Inc. 2010 Equity Incentive Award Plan (As Amended and Restated Effective May 27, 2021) Article 1 Purpose

from 10-K 83 pages Article 1. Definitions Section 1.1 Defined Terms Section 1.2 Additional Definitions Article 2 Research and Development Section 2.1 Development Programs Section 2.2 Delivery and Evaluation of Option Packages for Development Programs. Section 2.3 Regulatory Matters; Compliance Section 2.4 Subcontracting Section 2.5 Records and Audits Section 2.6 Manufacture and Supply Article 3 Management of the Collaboration Section 3.1 Joint Development Committee and Subcommittees Article 4 Grant of Rights to Zogenix Section 4.1 Zogenix Options Section 4.2 License Grants Section 4.3 Product Transfer Section 4.4 Rights Retained by the Parties Section 4.5 Government Rights Section 4.6 Section 365(n) of the Bankruptcy Code Article 5 Post-Exercise Activities Section 5.1 Zogenix Development and Commercialization Section 5.2 Tevard Option Section 5.3 Tevard Programs Article 6 Payments Section 6.1 Initial Fee Section 6.2 Investment |||

from 10-Q 16 pages Employment Agreement

from S-8 25 pages Zogenix, Inc. Employee Stock Purchase Plan

from 10-K 4 pages Amendment No. 1 to Exclusive License Agreement

from 10-K 11 pages Zogenix, Inc. 2010 Equity Incentive Award Plan Stock Option Grant Notice and Stock Option Agreement

from 10-Q 31 pages Supply Agreement on Fenfluramine Oral Solution by and Between Penn Pharmaceutical Services Limited and Zogenix International Limited

from 10-Q 33 pages Certain Information (Indicated by Asterisks) Has Been Omitted From This Document Because It Is Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. Exclusive License Agreement

from 8-K 20 pages Zogenix, Inc. 2010 Equity Incentive Award Plan (As Amended and Restated Effective May 22, 2019) Article 1 Purpose

from 10-Q 68 pages Certain Information (Indicated by Asterisks) Has Been Omitted From This Document Because It Is Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. Zogenix Inc. and Nippon Shinyaku Company Ltd. Distributorship Agreement

from 10-Q 30 pages Certain Information (Indicated by Asterisks) Has Been Omitted From This Document Because It Is Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. Master Supply Agreement by and Between Aptuit (Oxford) Limited and Zogenix International Limited

from 10-K 92 pages Lease Between Emery Station West, LLC (Landlord) and Zogenix, Inc. (Tenant) Emerystation West Emeryville, California Article 1 Basic Lease Provisions

from 10-K 4 pages Lease Termination Agreement

from 10-Q 30 pages Employment Agreement

from 10-Q 2 pages Zogenix, Inc. Independent Director Compensation Policy